78.30EUR-1.26%Mkt Cap: 49.01B $P/E: 54.001d ago
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement prod…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap49.01B $
Enterprise Value45.62B $
Revenue (TTM)7.08B $
Gross Profit5.14B $
Net Income (TTM)1.17B $
Revenue/Share12.20 USD
Last Price78.30 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16.0K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINUS28176E1082
Valuation
P/E (Trailing)54.00
P/E (Forward)—
PEG2.19
EV/EBITDA21.02
EV/Revenue6.44
P/S6.97
P/B4.95
EPS (TTM)1.45
EPS (Forward)—
52W Range
78.0615% of range79.66
52W High79.66 EUR
52W Low78.06 EUR
Profitability
Gross Margin78.01%
Oper. Margin29.84%
EBITDA Margin30.66%
Profit Margin17.69%
ROE10.38%
ROA7.84%
Growth
Revenue Growth13.60%
Earnings Growth-25.40%
Cash Flow & Leverage
Operating CF1.73B $
CapEx (TTM)282.83M $
FCF Margin18.92%
FCF Yield2.73%
Net Debt-3.86B $
Net Debt/EBITDA-1.78
Balance Sheet
Debt/Equity0.07
Current Ratio4.52
Quick Ratio3.45
Book Value/Sh15.92 EUR
Cash/Share7.378 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.576.40M
Float574.49M
Insiders0.19%
Institutions97.50%
Technical
SMA 5077.48 (+1.1%)
SMA 20072.80 (+7.5%)
Beta0.85
S&P 52W Chg20.80%
Avg Vol (30d)133
Avg Vol (10d)107
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—